Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much (a) his Department and (b) NHS England have spent on (i) Part IX, Value-Based Procurement and (ii) the MedTech Commercial Strategy reforms.

The Department and NHS England have spent:

• £1,067,157.34 directly on Part IX of the Drug Tariff, including VAT where applicable. This covers the period 2024/25 and planned spend up until the end of the 2025/26 financial year;
• £225,189 on Value Based Procurement during the current financial year, including VAT where applicable. This figure includes planned spend up until the end of the 2025/26 financial year. No spend on Value Based Procurement was identified during the 2024/25 financial year; and
• £120,000 planned direct spend for the Medtech Commercial Strategy, including VAT where applicable. This includes planned spend up until the end of the 2025/26 financial year.

These figures do not include the Department and NHS England staff time.